BEAMSTART Logo

A new biotechnology startup company aims to leverage gene-targeting technique to develop treatments for skin conditions.

The Next Web LogoThe Next Web1w ago

 A new biotechnology startup company aims to leverage gene-targeting technique to develop treatments for skin conditions. - The Next Web

Quick Summary:

Based in Boston and Geneva, Alys Pharmaceuticals is co-founded by Medicixi, a European healthcare-focused investment firm, and six university scientists, including Nobel Prize winner Craig Mello.

A new biotech startup developing immuno-dermatology technologies for skin diseases has launched today with $100mn (€93mn) in seed funding.

The startup is a merger of six individual companies in the field (also backed by Medicixi), which in combination boast 14 active R&D programmes.


More Pictures

 A new biotechnology startup company aims to leverage gene-targeting technique to develop treatments for skin conditions. - The Next Web (Picture 1)

or

Article Details

Author / Journalist: Ioanna Lykiardopoulou

Category: Technology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-02-12 @ 12:38:04 (1 weeks ago)

News Timezone: GMT +1:00

News Source URL: thenextweb.com

Language: English

Article Length: 437 words

Reading Time: 3 minutes read

Sentences: 19 lines

Sentence Length: 23 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © The Next Web

News ID: 20045991

View Article Analysis

About The Next Web

The Next Web Logo

Main Topics: Technology

Official Website: thenextweb.com

Year Established: 2006

Headquarters: Netherlands

News Last Updated: 2 days ago

Coverage Areas: Netherlands

Ownership: Independent Company

Publication Timezone: GMT +1:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #13

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story " A new biotechnology startup company aims to leverage gene-targeting technique to develop treatments for skin conditions." has 437 words across 19 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Which news outlet covered this story?

The story " A new biotechnology startup company aims to leverage gene-targeting technique to develop treatments for skin conditions." was covered 1 weeks ago by The Next Web, a news publisher based in Netherlands.

How trustworthy is 'The Next Web' news outlet?

The Next Web is a fully independent (privately-owned) news outlet established in 2006 that covers mostly technology news.

The outlet is headquartered in Netherlands and publishes an average of 0 news stories per day.

It's most recent story was published 2 days ago.

What do people currently think of this news story?

The sentiment for this story is currently Positive, indicating that people regard this as "good news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #20045991
  • URL: https://beamstart.com/news/new-biotech-startup-targets-genes-17077464151172

BEAMSTART brings you the latest news, databases, and jobs from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting community events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2024 BEAMSTART. All Rights Reserved.